CUDC-907, a dual inhibitor of PI3K and HDAC, can reduce MYCN levels in NB cells and increase H3K9Ac levels, promoting apoptosis (Chilamakuri and Agarwal, 2022). This evidence concerns the gene HDAC9 and neuroblastoma.